Venus Medtech (启明医疗) & Peijia Medical (沛嘉医疗) Placement - Take Your Pick
Venus MedTech (2500 HK) is looking to raise up to US$187m in its primary placement. At the same time, Peijia Medical (9996 HK) is looking to raise...
570 Views
MicroPort CardioFlow IPO Initiation: To Save a Life
MicroPort is pre-marketing for an HK IPO to raise $300 million. With a large addressable market opportunity and VitaFlow’s potentially best-in...
955 Views
MicroPort Cardioflow (微创心通) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market
The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...
628 Views
Microport Cardioflow: Winning in TAVR
We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.
550 Views
Hong Kong IPOs: Lock-Up Expiries (December 2020 Edition)
There exist the "moral hazard" around the expiry of lock-up periods. In 2020, IPO's have on average underperformed the HSI heading into the lock...
739 Views